Stockreport

Hepion’s NASH Drug Candidate, CRV431, Demonstrates Superior Antifibrotic Efficacy in Expanded Human Liver Study

Hepion Pharmaceuticals, Inc.  (HEPA) 
Last hepion pharmaceuticals, inc. earnings: 11/14 05:17 pm Check Earnings Report